Pulmonx (LUNG) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Pulmonx Corporation  (NASDAQ: LUNG)
 

Pulmonx Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Pulmonx's inventory turnover ratio sequentially decreased to 1.24 in the second quarter 2026, otherwise the ratio remained above the average, as LUNG's markets remain strong.Pulmonx's average inventory processing period in the Jun 30 2026 quarter, has increased to 294 days, from 281 days, in the Mar 31 2026 quarter.

Within Healthcare sector 291 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 644 in the first quarter 2026, to 1750.

LUNG Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Pulmonx Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LUNG Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 1.33 % -2.97 % -6.33 % -4.19 % -4.74 %
Y / Y Cost of Sales Growth -16.43 % -33.33 % -14.29 % 0 % 20 %
Inventory Turnover Ratio (TTM) 1.24 1.3 1.41 1.45 1.44
LUNG's Total Ranking # 1750 # 644 # 1314 # 1504 # 1367
Average inventory processing period 295 281 258 251 254
Seq. Inventory Growth 0.49 % 2.93 % -2.48 % 0.45 % -3.77 %
Seq. Cost of Sales Growth 25.35 % -33.33 % 20 % -16.67 % 0 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 135
Healthcare Sector # 292
Overall Market # 1750

Inventory Turnover Ratio Statistics
High Average Low
1.45 1.08 0.75
(Sep 30 2025)   (Sep 30 2022)



LUNG Company Profile >> Back to LUNG Efficiency Comparisons >> Compare LUNG Inventory Turnover Ratio to its Competitors

Financial Statements
Pulmonx's Inventories $ 16 Millions Visit LUNG's Balance sheet
Pulmonx's Cost of Revenues TTM $ 20 Millions Visit LUNG's Income Statement
What are LUNG's Sales? Visit LUNG's Sales by Segment

Other Inventory Turnover Ratios
Pulmonx's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LUNG's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LUNG's Competitors
Inventory Turnover Ratio for LUNG's Suppliers
Inventory Turnover Ratio for LUNG's Customers

You may also want to know
LUNG's Sales Growth Rates LUNG's Pe Price to earnings ratio LUNG's Receivables Turnover Ratio LUNG's Stock Quote
LUNG's Net Income Growth Rates LUNG's Ps Price to Sales ratio LUNG's Sales per Employee LUNG's Asset Turnover Ratio
LUNG's Net Margin LUNG's Pb Price to Book ratio LUNG's Financial Strength Ratios LUNG's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Gilead Sciences Inc   3.35 $ 6,217.000  Millions$ 1,857  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Biofrontera Inc   3.28 $ 6.622  Millions$ 2  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Solventum Corporation  3.22 $ 3,421.000  Millions$ 1,061  Millions
Agilent Technologies inc   3.20 $ 3,404.000  Millions$ 1,064  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Zevra Therapeutics Inc   3.14 $ 6.180  Millions$ 2  Millions
Prestige Consumer Healthcare Inc   3.13 $ 513.522  Millions$ 164  Millions
Eton Pharmaceuticals Inc   3.11 $ 44.176  Millions$ 14  Millions
Becton Dickinson And Company  3.09 $ 11,161.000  Millions$ 3,615  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Revvity Inc  2.98 $ 1,136.473  Millions$ 381  Millions
Amneal Pharmaceuticals Inc   2.98 $ 1,891.689  Millions$ 635  Millions
Akebia Therapeutics Inc   2.96 $ 44.632  Millions$ 15  Millions
Msa Safety Inc  2.92 $ 1,021.036  Millions$ 350  Millions
Ligand Pharmaceuticals Incorporated  2.91 $ 32.387  Millions$ 11  Millions
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions
Iovance Biotherapeutics inc   2.81 $ 152.872  Millions$ 54  Millions
Livanova Plc  2.79 $ 468.065  Millions$ 168  Millions
Merck and Co Inc   2.79 $ 17,996.000  Millions$ 6,447  Millions
Inspiremd Inc   2.78 $ 8.847  Millions$ 3  Millions
Dentsply Sirona Inc   2.77 $ 1,839.000  Millions$ 663  Millions
Ani Pharmaceuticals Inc  2.69 $ 387.398  Millions$ 144  Millions
International Stem Cell Corporation  2.61 $ 4.285  Millions$ 2  Millions
Biomerica Inc   2.59 $ 4.091  Millions$ 2  Millions
Evofem Biosciences Inc   2.58 $ 4.418  Millions$ 2  Millions
Nephros Inc   2.54 $ 8.991  Millions$ 4  Millions
Illumina Inc   2.52 $ 1,510.000  Millions$ 599  Millions

Date modified: 2026-08-31T03:27:13+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.